Systematic reviews and meta-analyses form the basis for evidence-based dentistry. Evidence-based dentistry has become popular in recent years, which utilizes the best available research evidences with clinical experience and patient needs. In the hierarchy of studies, meta-analysis and systematic reviews occupy the highest levels. Systematic reviews and meta-analyses are the essential tools as they help in summarizing diff erent available information reliably so as to draw the conclusion more accurately. A systematic review is the process of searching clinical evidence on a particular topic and selecting quality articles, appraising, and synthesizing to draw conclusion. Conducting a systematic review involves proper methodology as described in the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA).
Introduction
Systematic review summarizes diff erent researches with the same aim more accurately and reliably. Systematic reviews are not only essential for clinicians for keeping them updated regarding treatment, but also to policymakers to judge risk and benefi ts of any intervention. In meta-analysis, we combine the results of diff erent independent studies and apply statistical tests. Systematic review may or may not contain meta-analysis. Initially, the entire process was termed meta-analysis. Now, meta-analysis is considered as a component of systematic review. It is not always possible to perform meta-analysis due to clinical, methodological, and statistical diff erences across individual studies.
Thus, a systematic review is an overview of primary studies of high quality. There are some guidelines that should be followed while writing a systematic review article so as to correctly interpret the result. Systematic review combines information from individual studies, and thus, it has an overall sample size that is greater than that of any other studies and it synthesizes all relevant studies on a specifi c topic. Systematic review methods can be applied to any type of study -may it be epidemiological or randomized trials or any other type. Meta-analysis is the statistical method to explain and combine the results of studies included in review articles.
The key features of a systematic review involve: (a) Formulating the objective (b) searching diff erent studies
An introduction includes objective of the review along with the statement regarding the necessity of review. It should be brief and should clearly state the aim of the review and questions being addressed with reference population under study such as age of participants, type of study, exposure, control group, and type of study design.
Methods

Protocol and registration
A protocol sets the objective and method for conducting a systematic review article.
The methods for study searching, screening, data extraction, and analysis should be contained in a proper written document to minimize bias before starting the study search. Registration of systematic review helps in reducing the publication bias. The Cochrane collaboration has established the Cochranecontrolled trials register, which contains records of controlled trials. If all trials are registered, the results of all trials (positive as well negative) are available for reporting systematic reviews. This avoids publication bias so that meta-analyses and systematic reviews are not aff ected adversely. Registration can be done on the following sites:
www.clinicaltrials.gov, www.lib.umi.com/dissertations, and www.controlled-trials.com.
Inclusion criteria of study
Eligibility criteria are essential in knowing the validity, applicability, and comprehensiveness of issues. They infl uence search strategy and then serve to ensure that studies are selected in a systematic and unbiased manner. Strict inclusion and exclusion criteria for studies are recommended. Study eligibility criteria likely to include are the participants under study, interventions, control group, outcomes, and study designs of interest. Inclusion criteria may also be language of publication, publication status whether unpublished material also used or not, and year of publication.
Information sources (search)
It requires description of all information sources (databases, platform, or search media, e.g., Ovid, Dialog, and PubMed). The start and end dates of coverage of the search and contact with diff erent study authors should also be described. Interested reader accesses comprehensiveness and completeness of search and may try to duplicate it. Unpublished literature can be searched through various sites such as:
Study selection
There is no standard process of selecting the studies for systematic review article, yet it should be described. Author records large number of studies from diff erent search engines and includes the relevant study according to the eligibility criteria and excludes the studies that do not meet the eligibility criteria. PRISMA fl ow diagram is used to describe the selection processes of diff erent studies. Two reviewers independently select the studies. Any disagreement is resolved by general concusses. The views of two investigators reduce the possibility of missing a relevant study.
Data items and data collection process
Authors draw information from diff erent selected studies so as to summarize and present evidence of a systematic review. Some authors use data collection form. The data collection forms vary for diff erent systematic reviews. Depending on the particular systematic review, more specifi c data collection items may need to be extracted for appropriate review. Data items should include the list of all variables, for which data were extracted such as age of participants, severity of disease, method of diagnosis, inclusion and exclusion criteria, duration of treatment, and any assumptions and simplifi cations made about missing or unclear information.
Risk of bias in individual studies
The result of systematic review is closure to the truth if the included studies are valid. The risk of bias in an individual study is assessed by assessing its methodology because the treatment eff ect reported in any study is true when the study is valid. The methodological characteristics may aff ect the eff ect sizes. Hence, it is necessary to describe the method so as to access the risk of bias (whether the results are actual or biased). Validity of a method depends on random allocation sequence, concealment of allocation sequence, blinding (participants, treating doctor, data collector or analyzer, and outcome adjudicators), number of patients lost to follow-up, stopping of trials early for benefi ts, and whether analysis is followed with intention-to-treat principle or not. Conclusions: Th ere is some evidence that the use of a daily NaF mouthrinse or a GIC for bonding brackets might reduce the occurrence and severity of WSL during orthodontic treatment. More high quality, clinical research is required into the diff erent modes of delivering fl uoride to the orthodontic patients. [2] Introduction Rationale: Introduction includes the rationale for the review in the context of what is already known.
3 Th e most compelling potential advantages attributed to self-ligating brackets are a reduction in overall treatment time and less associated subjective discomfort.
Other improvements include more effi cient chairside manipulation and promotion of periodontal health due to poorer biohostability. Preliminary retrospective research has pointed to a defi nite advantage, with a reduction in overall treatment time of 4-7 months and a similar decrease in required appointments. Consequently, the use of SLBs has increased exponentially; over 42% of American practitioners surveyed reported using at least one system in 2008. [9] Th is fi gure was just 8.7% in 2002. [3] Objective 4 Th e purpose of this systematic review is to evaluate the clinically signifi cant eff ects of SLBs on orthodontic treatment with respect to the quality of scientifi c evidence and the methodology of those reports. [3] Methods Protocol and registration 5 Protocol is important as it specify the objective and method of systemic review article. Registration of systemic reduces the publication bias. Th e Cochrane Collaboration has established the Cochrane Controlled Trials Register, which contains the records of controlled trials.
Eligibility criteria 6 [4] (Contd...) Reference lists of the included studies were screened for relevant research. [3] Study selection 9 (Described in result section as item number)
Th is systemic review was done to evaluate the clinical diff erences in relation to the use of self-ligating brackets in orthodontics. Forty-three trials were initially deemed potentially relevant to the review, 42 being derived from MEDLINE via OVID and 1 study from the National Research. Register 11 (www.controlled-trials.com). Following detailed assessment, 13 satisfi ed the inclusion criteria. One of these was subsequently omitted following retrieval of the full-text article; the remaining 30 studies were also excluded. However, aft er contacting the authors of published trials, a further fi ve studies were also included.
Of the 17 papers selected, 6 were randomized controlled trials. [3] PRISMA fl ow diagram to summarize study selection processes:
Data collection process and data items 10, 11 Th is study was done to perform a meta-analysis of the literature concerning the optimal force or range of forces for orthodontic tooth movement. Aft er applying the exclusion criteria, 17 of 161 articles on animal studies and 12 of 305 articles on human studies included in the review. From each study that remained aft er application of the exclusion criteria, the data were extracted as follows: Th is systemic review was done to evaluate the clinical diff erences in relation to the use of self-ligating brackets in orthodontics. Six key methodological criteria were assessed: Sample size calculation, random sequence generation, allocation concealment, reporting of withdrawals, blinding of measurement assessment, and the use of intention-to-treat analysis. An overall assessment of risk of bias (high, medium, and low) was undertaken for each included trial using Cochrane Collaboration criteria. When fi ve or more quality items were met, studies were considered to have a low risk of bias; three or more had medium risk; studies fulfi lling less than three criteria were deemed to have a high risk of bias. Only those at low-to-medium risk of bias were to be considered for meta-analysis. [3] Summary measures 13 "A meta-analysis was performed using the metan command in Stata version 11.2 (StataCorp, College Station, Tex). As the studies selected in this analysis were carried out in diff erent countries and populations, between-study variations were assumed a priori. Hence, random eff ect models were used in the meta-analysis, which takes into account both within-and between-study variations in eff ect sizes. " [6] Synthesis of results 14 A meta-analysis was performed using the metan command in Stata version 11.2.
As the studies selected in this analysis were carried out in diff erent countries and populations, between-study variations were assumed a priori. Hence, random eff ect models were used in the meta-analysis, which takes into account both within-and between-study variations in eff ect sizes. To test whether there was more heterogeneity in the data than the chance, Q test was used. Th e heterogeneity measure I2 was also calculated to measure the percentage of heterogeneity in the data. [6] Risk of bias across studies 15 (Describe it in result as item number 22)
Funnel plots are used to assess the publication bias visually" (A funnel plot is a graph designed to check for the existence of publication bias; funnel plots are commonly used in systematic reviews and meta-analyses. In the absence of publication bias, it assumes that the largest studies will be plotted near the average, and smaller studies will be spread evenly on both sides of the average, creating a roughly funnel-shaped distribution. Deviation from this shape can indicate publication bias).
An example funnel plot, each dot represents a study; the y-axis represents the size of the study (e.g., number of experimental subjects) and the x-axis shows the study's result. [6] (Contd...) Forty-three trials were initially deemed potentially relevant to the review, 42 being derived from MEDLINE via OVID and 1 study from the National Research. Register 11 (www.controlled-trials.com). Following detailed assessment, 13 satisfied the inclusion criteria. One of these was subsequently omitted following retrieval of the full-text article; the remaining 30 studies were also excluded. However, after we contacted the authors of published trials, a further five studies were included. Of the 17 papers selected, 6 were randomized controlled trials. [3] Study characteristics 18 All 25 studies were observational and were organized into three groups according to the type of comparisons made: (1) 11 studies (9-19) comparing groups with and without malocclusion/orthodontic treatment need (independent groups design), (2) 10 studies (20-29) comparing the same group of individuals before and aft er treatment (labeled as pre-post design), and (3) four studies (30-33) comparing an orthodontically treated group with an independent group requiring treatment (treated-untreated) groups' design. [6] Risk of bias within studies 19 (see item number 12)
Refer to item number 12.
(Contd...)
Check list Content Item
Checklist items of PRISMA with relevant example Results of individual studies 20 Forest plot is the graphical display of results of meta-analysis. Results of individual study are presented with eff ect estimates and confi dence intervals, ideally with a forest plot. Forest plots are commonly presented with two columns-left -hand column names of the studies in chronological order from the top downward, right-hand column-plot of the measure of eff ect, for example, an odds ratio has confi dence intervals represented by horizontal lines. Area of each square is proportional to the study's weight in the meta-analysis. Overall, meta-analyzed measure of eff ect is oft en represented on the plot as a dashed vertical line. Th is meta-analyzed measure of eff ect is commonly plotted as a diamond, the lateral points of which indicate confi dence intervals for this estimate. [7] Synthesis of results 21 Among the studies that used OHIP-14, only a few used the same type and details of reporting. Only eight of the 25 studies included in the review (32%) provided information on the OHIP-14 mean and standard deviation as well as the sample size of the groups compared, namely, three of the 11 using the pre-post design, four of the 10 using the independent groups design, and one of the four using the treated-untreated groups' design. Th e three and four studies in the fi rst and second study designs were amenable to meta-analysis. Th e remaining 18 studies were excluded from the meta-analysis. Th e contribution of each study to the meta-analysis is given as a percentage of weight. For the four studies that used the pre-post study design, the standardized mean diff erence (SMD) was 1.29 (95% CI: 0.67-1.92), indicating that the OHIP-14 score decreased aft er treatment. Similarly, for the three studies that used the independent groups study design, the SMD was 0.84 (95% CI: 0.25-1.43), indicating that people without malocclusion had lower OHIP-14 scores compared with their counterparts. Th e mean SMD score was signifi cantly diff erent from 0 in both cases (P<0.001 and 0.005, respectively). Th e studies involved in each meta-analysis were heterogeneous, and the heterogeneity was statistically signifi cant ((P<0.047 and, 0.001) for the fi rst and second meta-analysis, respectively). Th e variations in SMD measured as a percentage were 67.2% (pre-post study design) and 91.6% (independent group study design). Th e between-study variance was 0.20 and 0.34 for the pre-post and independent-group study designs, respectively. [6] Risk of bias across study 22 See item number 15. "Th e sensitivity analysis indicated that the omission of any of the studies led to a new estimate of 0.81 (95% CI: 0.25-1.43) that fi ndings varied widely between the populations and countries where the primary studies were conducted. " Sensitivity analyses are used to explore the degree to which the main fi ndings of a systematic review are aff ected by changes in its methods or in the data used from individual studies (e.g., study inclusion criteria, results of risk of bias assessment. [6] 
Summary measures
When planning a systematic review, it is advised that author should pre-specify the outcome measure. Most common summary measures are the risk ratio, odds ratio, and risk diff erence for binary outcomes. For continuous outcomes, we measure diff erence in means.
Planned methods of analysis
The data gathered from the studies are analyzed to decide whether meta-analysis can be performed or not. In case of heterogeneity between included studies, meta-analysis cannot be performed. If it is included, the authors should mention the eff ect measure (e.g., relative risk or mean diff erence). The statistical consideration is most technical and evidence-based. For combining data in a meta-analysis, two types of statistical models are used commonly: (1) Fixed eff ects model (common treatment eff ect for all included studies) (2) Random eff ects model (variation of eff ects across studies).
Risk of bias across studies
Publication bias may distort meta-analysis and systematic reviews because these reviews rely on a large number of studies.
Publication bias is caused by the fact that results showing signifi cant fi ndings are published and the results that are negative are not published. Thus, studies with signifi cant results do not appear to be superior with respect to the quality of design. To avoid publication bias, registration of trials is done, and thus, studies with unfavorable results are also available to be included and are not withheld from publication.
Authors should examine results from the available studies for missing studies (publication bias) or missing data in the included studies (selective reporting bias). Bias toward reporting signifi cant results despite the fact that number of studies with negative results are higher is known as publication bias.
There are certain other analysis (sensitivity analysis, subgroup analysis, meta-regression analysis, etc.), which are applied depending on the aim of review.
Results
Study selection
Authors should give the total numbers of studies screened along with that the information of whether they are selected or rejected with reason of their acceptance or rejection with a fl ow diagram.
Check list
Content Item Checklist items of PRISMA with relevant example Discussion Summary of evidence 24 Authors should summarize the main fi ndings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., health-care providers, users, and policymakers). "Th is review has found some evidence that a daily sodium fl uoride mouthrinse will reduce the severity of demineralization associated with orthodontic appliances and that GIC used for bonding reduces the incidence and severity of WSL compared with a composite resin. However, considering the widespread use of fl uoride products during orthodontic treatment, there is little evidence as to which method or combination of methods to deliver the fl uoride is the most eff ective for orthodontic patients. [2] Limitations 25 Discuss the limitations at study and outcome level (e.g., risk of bias) and at review level (e.g., incomplete retrieval of identifi ed research, reporting bias). "In the quality analysis, 6 of the 22 studies were judged to be of medium/high quality [ Table 4 ]. Four of these 6 articles were RCTs. Th e reason for a medium/high quality score instead of a high score is that these studies had some methodological limitations.
• Th e article by O'Brien et al. gave no statistical analysis for the mandibular skeletal changes.
• Th e RCTs by Jakobsson, Nelson et al., and Tulloch et al., did not use blinding in measuring the cephalometric parameters.
• On the other hand, 2 CCTs were judged to be of medium/high quality, whereas most CCTs were judged to be of medium quality. [8] Conclusion: Conclusion should be realistic and not too optimistic in the context of other evidence and give idea for future research 26 "Titanium TSADs do off er direct structural and functional anchorage according to the Branemark's defi nitions. Future research should target specifi c issues by using well-controlled experimental models. " "Titanium skeletal anchorage device off ers direct structural and functional anchorage even with a level of osteointegretion as low as 5%. Future research about optimum loading for stability is required for diff erent specifi c issues with well-controlled experimental design. " [9] Funding 27 Author should describe the sources of funding or other support (e.g., supply of data) for the systematic review; role of funders for the systematic review.
PRISMA: Preferred Reporting Items for Systematic Review and Meta-analysis This helps in knowing the validity and applicability of a systematic review. Authors should provide a source of information of the included studies. Authors should describe suffi cient details of diff erent included studies to make their own judgment. Author should not assume any information that is missing in the study (e.g., sample size and method of randomization). The PICOS framework (population, intervention, comparator, outcome, and study design) is useful in reporting the clinical characteristics, disease, methods of the intervention, and of the comparison group.
Risk of bias within studies
Assessment of the risk of bias of included studies can be performed using any standard approach. For example -Cochrane collaboration's criteria for assessing the risk of bias.
Results of individual studies and its synthesis
Authors should give unadjusted estimates and confounderadjusted estimates and their precision (e.g., 95% confi dence interval) in individual studies. Make clear which confounders were adjusted for and why they were included. For continuous outcomes, the mean, standard deviation, and sample size for each group are described. To know time-to-event ratio, the authors should determine the log hazard ratio (it is the limits of the number of event per unit time divided by the number of risk, as the time interval approach zero) and standard error for included study.
The main result of the review should be presented at fi rst. If meta-analyses are done, confi dence intervals and measures of consistency are included. Meta-analysis is neither always indicated nor feasible because of clinical heterogeneity between studies with regard to populations, interventions, or form of outcome assessment. If meta-analysis was not performed, possible explanation should be given for not performing metaanalysis, and inferences should be presented systematically.
Additional analyses
Additional analyses such as sensitivity analysis, subgroup analysis, and meta-regression (if done) should be reported, whether the result is statistically signifi cant or not, to avoid selective outcome reporting bias within the review.
Discussion
Summary of evidence and limitations
Authors should explain the main fi ndings for each outcome along with their pertinence to key groups (e.g., health-care providers, users, and policymakers). While interpreting results, one should keep in mind that statistical signifi cant results may not be necessary clinically signifi cant and thus, may not suggest clinical or policy relevance. Similarly, statistically nonsignifi cant results may not indicate that a treatment is ineff ective. Authors should also discuss the limitations of the study such as risk of bias and reporting bias. Publication bias might account for the eff ects observed. Asymmetric funnel plot suggests the selective reporting, which cause the overestimation of eff ect size. Limitation addresses validity (risk of bias) and reporting or information of the included study, limitation of review process, and generalizability and reliability of review. Limitation of review process includes: (a) Limitation of the search restricting to few search engines (b) Any other particular language publication (English only).
Conclusion
Authors should give a brief and balanced statement on fi ndings of the review. Drawing conclusion should be realistic and should not be too optimistic. If conclusion is not drawn because of insuffi cient number of reliable study or because of uncertainty, it should be declared in the study. Such a fi nding can be as important as fi nding consistent eff ects from several large studies. Authors should also make explicit recommendations for further research. Systematic reviews have capability for guiding future clinical research.
Funding
Authors should describe the role of funding source and role of funder in the study design, collection of data, analysis, interpretation of data, or writing of report, etc., with transparency in systematic review. Whether they accept the responsibility of content or not should be mentioned. Sometimes, funding will be provided by ICMR, CDC center, or the department of science and technology.
PRISMA extensions
Certain extensions to PRISMA guidelines have been proposed for improving systematic review, such as PRISMA-Equity 2012. Healthy equity refers to study and cause of diff erence and quality of health and health care across diff erent populations. Hence, equity refers to the absence of disparity in controllable or remedial aspect of health. Inequity implies some kind of social injustice. PRISMA extension provides structured guidance on transparently reporting the methods and results and to legitimize and emphasize the importance of reporting health equity. [10] Despite published guidance on writing the abstract in the PRISMA statement, there is a poor reporting of abstracts. Hence, an extension to the PRISMA statement for good reporting of abstracts is developed. [11] Another extension called PRISMA-individual participants data (IPD), which includes integrity of IPD (in method and result), for explanation of variation in eff ect is developed. [12] PRISMA-Harm has also been developed as an extension to PRISMA to improve reporting and to encourage a balance statement of benefi ts and harms of diff erent interventions, for example, length of follow-up of treatment, measurement of any associated risk factor, etc. [13] Traditionally, meta-analyses have compared only two interventions at a time. Hence, another extension of the PRISMA statement was developed specifi cally to improve the reporting of systematic reviews, which incorporated network meta-analysis that allows comparisons between more than two interventions. Five new items were added in this extension (32-item PRISMA extension checklist). [14] PRISMA guidelines are developed to reduce fl aws and to improve the clarity and transparency in reviews. Here, we have provided a brief step-by-step explanation of the principles for all the items of PRISMA guidelines. This review paper provides a brief, simple, step-by-step guideline, which will help researchers to conduct systematic reviews.
